PolarityBio to Present Phase 3 SkinTE Data at SAWC Fall 2026
SALT LAKE CITY — September 29, 2026 PolarityBio announced that results from its pivotal Phase 3 COVER DFUS II...
clinical trial
Advertisement
Mirum Pharmaceuticals Wins FDA Approval for ATEBRIOZ
Foster City, California & Wilmington, Delaware, September 25, 2026 Mirum Pharmaceuticals and Incyte have announced a major regulatory milestone...
REGENXBIO Reports Three-Year Data for Surabgene in Retinopathy
Rockville, Maryland, U.S., September 24, 2026 REGENXBIO Inc. has presented three-year clinical data for surabgene lomparvovec in patients with...
Atavistik Bio Partners With Roche on Allosteric Drug Discovery
Cambridge, Massachusetts, U.S., September 24, 2026 Atavistik Bio has announced a strategic research collaboration with Roche to discover and...
Eton Launches U.S. Commercial Availability of IMPAVIDO
DEER PARK, Ill. — September 28, 2026 Eton Pharmaceuticals, Inc. announced the U.S. commercial launch of IMPAVIDO® (miltefosine) capsules,...
Advertisements
Glycomine Gains FDA Breakthrough Status for GLM101
San Carlos, California, U.S., September 24, 2026 Glycomine, Inc. has announced that the U.S. Food and Drug Administration (FDA)...
Tiziana Doses First Participants in ALS Foralumab Trial
BOSTON, Mass. — September 28, 2026 Tiziana Life Sciences, Ltd. announced that the first three participants have been dosed...
Sagimet to Present 52-Week Denifanstat Data at KOL Event
FOSTER CITY, Calif. — September 28, 2026 Sagimet Biosciences Inc. announced that it will host a virtual key opinion...
MediciNova Reports Phase 2 MN-001 Results in Metabolic Disease
LA JOLLA, Calif. — September 28, 2026 MediciNova, Inc. reported topline results from the randomized, double-blind, placebo-controlled MN-001-NATG-202 Phase...
HUTCHMED Initiates Global Phase I Trial of HMPL-A830
HONG KONG, SHANGHAI and FLORHAM PARK, N.J. — September 28, 2026 HUTCHMED (China) Limited announced the initiation of the...
Advertisement
